PREVAIL THERAPEUTICS INC's ticker is PRVL and the CUSIP is 74140Y101. A total of 77 filers reported holding PREVAIL THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $12,502,000 | +154.4% | 541,875 | +12.2% | 0.00% | +100.0% |
| Q3 2020 | $4,915,000 | +29.1% | 482,801 | +88.9% | 0.00% | 0.0% |
| Q2 2020 | $3,808,000 | +20.7% | 255,555 | -1.2% | 0.00% | 0.0% |
| Q1 2020 | $3,154,000 | -28.1% | 258,749 | -6.7% | 0.00% | 0.0% |
| Q4 2019 | $4,389,000 | +48.6% | 277,281 | +15.3% | 0.00% | – |
| Q3 2019 | $2,953,000 | +98333.3% | 240,460 | +120130.0% | 0.00% | – |
| Q2 2019 | $3,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|